Home Tags Oxycontin
"This milestone settlement should be approved now -- not delayed, deferred, or risked,” the Stamford drug maker said in a statement.
“Preserving Purdue’s ability to continue selling opioids as a public benefit corporation is simply unacceptable," Connecticut Attorney General William Tong said.
The states attorneys general question if Purdue Pharma is receiving special treatment.
Purdue Pharma said its request was not "out of a desire to benefit or protect" anyone, "including any member of the Sackler families."
The families of late Purdue Pharma owners Mortimer and Raymond Sackler said they have “deep compassion for the victims of the opioid crisis” and believe the settlement “is an historic step toward providing critical resources that address a tragic public health situation.”
Legal officials in 27 other states, as well as attorneys for over 2,000 cities and counties, have tentatively agreed to a plan with the Stamford-based maker of OxyContin.
A Purdue spokeswoman maintains that the firm "believes a settlement that benefits the American public now is a far better path than years of wasteful litigation and appeals."
The proposed agreement also calls for members of the Sackler family to give up ownership of Purdue, according to reports.
According to one email about the Stamford company's products, "if people die because they abuse it then good riddance."
Although the Stamford company recently settled a lawsuit filed against it by Oklahoma for $270 million, Connecticut will not be settling its suit.
The ruling does not affect the numerous other lawsuits filed across the country against Purdue, Endo, Janssen and others.
Rival opioid manufacturer Assertio Therapeutics filed the lawsuit against the Stamford-based company in 2013.
The Stamford-based firm also named Marc Kesselman, once general counsel of the U.S. Department of Agriculture, as senior vice president and general counsel.
12Page 1 of 2